- CA$352.20m
- CA$319.41m
- CA$52.51m
- 96
- 30
- 75
- 75
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 38.04 | ||
| PEG Ratio (f) | 1.49 | ||
| EPS Growth (f) | 34.34% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.26 | ||
| Price to Tang. Book | 46.89 | ||
| Price to Free Cashflow | 17.72 | ||
| Price to Sales | 6.53 | ||
| EV to EBITDA | 30.2 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.34% | ||
| Return on Equity | 7.92% | ||
| Operating Margin | 10.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 10.23 | 13.79 | 24.66 | 39.97 | 52.51 | 63.47 | 71.77 | 41.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +53.65 | +21.69 | +45.75 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
VitalHub Corp. is a Canada-based software company. The Company offers software for health and human service providers designed to simplify the user experience and optimize outcomes. It offers a comprehensive suite of software-as-a-service (SaaS) solutions, which include electronic health record (EHR), case management, care coordination, and optimization; patient flow, operational visibility, and patient journey optimization, and workforce automation. Its solutions include Alamac, Beautiful Information, Hicom, Intouch with Health, MCAP, Oculys, SHREWD, Synopsis, B Care, CaseWORKS, Pirouette, S12 Solutions and TREAT. Its clients include hospitals, regional health authorities, mental health and addictions services providers for children and adults, long-term care facilities, home health agencies, correctional services, and community and social services providers. It serves clients across Canada, the United States, the United Kingdom, Australia, the Middle East, and Europe.
Directors
- Daniel Matlow PRE
- Brian Goffenberg CFO
- Niels Tofting EVP
- Vijit Coomara EVP
- Robert Lazar EVP
- Andre Vandenberk OTH
- Roger Dent IND
- Stephen Garrington IND
- Chris Schnarr IND
- Francis Shen IND
- Tony Shen IND
- Barry Tissenbaum IND (73)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- January 9th, 2015
- Public Since
- July 3rd, 2015
- No. of Employees
- 353
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 50,823,090
- Address
- 480 University Avenue, Suite 1001, TORONTO, M5G 1V2
- Web
- https://vitalhub.com/
- Phone
- +1 6479654721
- Auditors
- MNP LLP
Upcoming Events for VHI
Vitalhub Corp Annual Shareholders Meeting
Q2 2024 Vitalhub Corp Earnings Release
Q3 2024 Vitalhub Corp Earnings Release
Similar to VHI
Bausch + Lomb
Toronto Stock Exchange
Hamilton Thorne
Toronto Stock Exchange
Profound Medical
Toronto Stock Exchange
Sernova
Toronto Stock Exchange
Titan Medical
Toronto Stock Exchange
FAQ
What is the Vitalhub share price?
As of Today at 12:04 UTC, shares in Vitalhub are trading at CA$7.09. This share price information is delayed by 15 minutes.
How has the Vitalhub share price performed this year?
Shares in Vitalhub last closed at CA$7.09 and the price had moved by +167.55% over the past 365 days. In terms of relative price strength the Vitalhub share price has outperformed the Toronto Stock Exchange 300 Composite Index by +141.03% over the past year.
What are the analyst and broker recommendations for Vitalhub?
The overall consensus recommendation for Vitalhub is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Vitalhub dividend yield?
Vitalhub does not currently pay a dividend.
Does Vitalhub pay a dividend?
Vitalhub does not currently pay a dividend.
When does Vitalhub next pay dividends?
Vitalhub does not currently pay a dividend.
How do I buy Vitalhub shares?
To buy shares in Vitalhub you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vitalhub?
As of the previous close price of CA$7.09, shares in Vitalhub had a market capitalisation of CA$360.34m.
Where are Vitalhub shares listed?
Here are the trading details for Vitalhub:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: VHI
What kind of share is Vitalhub?
Based on an overall assessment of its quality, value and momentum Vitalhub is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vitalhub share price forecast for 2024?
The analyst consensus target price for shares in Vitalhub is CA$8.08. That is 13.96% above the last closing price of CA$7.09.
Analysts covering Vitalhub currently have a consensus Earnings Per Share (EPS) forecast of CA$0.15 for the next financial year.
What is the trend in the Vitalhub share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vitalhub. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +64.2%.
As of the last closing price of CA$7.09, shares in Vitalhub were trading +43.48% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vitalhub PE Ratio?
The Vitalhub PE ratio based on its reported earnings over the past 12 months is 38.04. The shares last closed at CA$7.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vitalhub?
Vitalhub's management team is headed by:
- Daniel Matlow - PRE
- Brian Goffenberg - CFO
- Niels Tofting - EVP
- Vijit Coomara - EVP
- Robert Lazar - EVP
- Andre Vandenberk - OTH
- Roger Dent - IND
- Stephen Garrington - IND
- Chris Schnarr - IND
- Francis Shen - IND
- Tony Shen - IND
- Barry Tissenbaum - IND